Author

Gaosi Xu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease.

AIM To compare the cardiorenal efficacy and safety of finerenone, sodium-glucose cotransporter 2 inhibitors (SGLT2i), semaglutide and finerenone-SGLT2i combination therapy in diabetic kidney disease (DKD). MATERIALS AND METHODS PubMed, Embase and CENTRAL were searched through July 9, 2026 for randomized trials involv...

Zi-Jian Zhou, Ling-Hua Fu, Dan Chen et al. · Diabetes, obesity and metabo... · 0 citations

Review Open access Jul 2026

Gut microbiota dysbiosis and immune responses: insights from IgA nephropathy and inflammatory bowel disease

IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide, and inflammatory bowel disease (IBD) comprises a group of chronic, relapsing inflammatory bowel disorders. Although IgAN and IBD differ in clinical manifestations, both involve interactions among genetic susceptibility, epigenetic abnormalities, an...

Lusia S. Yi, Ran Zhang, Yang Yang et al. · Frontiers in Immunology · 0 citations